X-Biotix Therapeutics' Series A Round

X-Biotix Therapeutics raised a round of funding on April 24, 2018.

X-Biotix Therapeutics is a biotechnology company specializing in the development of novel small molecule antibiotic scaffolds for multi-drug resistant (MDR) Gram-negative pathogens to address the grow…

Articles about X-Biotix Therapeutics' Series A Round: